RZRuihong Zhao

Ruihong Zhao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ruihong Zhao has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Jianke Ma

    B Department of Infectious Diseases , Cixi People's Hospital , Cixi , China

    2 shared publications
  • Bao-Yan Xu

    Department of Infectious Diseases, Southwest Hospital, Third Military Medical, University (Army Medical University), Chongqing, China

    1 shared publication
  • Bei-Ling Li

    Hepatology Unit, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China

    1 shared publication
  • Chen Wang

    Department of Infectious Diseases, Taihe Hospital, Hubei University of Medicine, Hubei, China

    1 shared publication
  • Chun-Yan Liu

    Department of Hepatology, The First Hospital of Jilin University, Jilin, China

    1 shared publication
  • Cong-Cong Zou

    Department of Infectious Diseases, Institute of Infection and Immunology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei, China

    1 shared publication

Latest Publications

  • Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation

    by Yan Zhang, Bao-Yan Xu, Xian-Bo Wang, Xin Zheng, Yan Huang, Jinjun Chen, Zhong-Ji Meng, Yan-Hang Gao, Zhi-Ping Qian, Feng Liu, et al.


  • Epidemiological investigation of non-fermentative bacterial infection in cirrhotic patients

    by Qi Xia, Ruihong Zhao, Haotang Ren, Hong Fang, Yina Wang

    Background: This study aimed to describe the clinical characteristics of NFGNB in patients with cirrhosis as well as the risk factors for short-term mortality. Methods: A retrospective analysis was performed in patients with cirrhosis and NFGNB infections from 2011 to 2016 in the First Affiliated Hospital of Zhejiang University. Results: 144 episodes in 134 patients with liver cirrhosis and NFGNB infections were found in total. Of these, 81.2% were hospital-acquired or healthcare- associated infections, while only 18.8% of NFGNB infections originated from the community. A. baumannii were the most frequently isolated bacteria (39 episodes), followed by S. maltophilia and P. aeruginosa (38 and 31 episodes, respectively). MDR- and non-MDR-NFGNB comprised 62.5% (90/144) and 37.5% (54/144) of infections respectively. The Kaplan-Meier survival curve showed no significant difference between MDR and non-MDR NFGNB patients (74.1% vs 75.5%, P=0.811). Neither MDR or the subgroup of common NFGNB (P. aeruginosa, A. baumannii, S. maltophilia) was associated with the 28-day mortality (all P values >0.05). Low albumin levels and high Tbil levels were both independent risk factors for 28-day mortality (HR=0.930, 95%CI (0.869, 0.995), P=0.035; HR=1.003, 95%CI (1.002, 1.005), P<0.001, respectively). Conclusions: Diabetes increased 28-day mortality significantly, however, MDR status, site of infection and bacteria type did not.


  • Upper gastrointestinal hemorrhage in acute-on-chronic liver failure: prevalence, characteristics, and impact on prognosis

    by Hong Zhao, Ruihong Zhao, Jianhua Hu, Xuan Zhang, Jianke Ma, Yemin Shi, Weihang Ma, Jifang Sheng, Lanjuan Li

    Background: Upper gastrointestinal hemorrhage (UGH) is a life-threatening complication in patients with cirrhosis; however, data regarding the role of UGH in acute-on-chronic liver failure (ACLF) are limited. Methods: A prospective, observational cohort study was performed from February 2014 to Mach 2015. Results: UGH was identified in 170 of 492 cirrhotic patients with acute decompensation (AD) at the time of admission. Logistic regression analysis showed that fecal occult blood test positivity was an independent risk factor for UGH in patients with or without ACLF [OR(95%CI): 8.31(4.89–14.10), p<0.001; and 6.29 (1.48–26.76), p=0.031]. Other independent risk factors were a history of gastrointestinal bleeding [OR(95% CI): 13.43 (7.17–25.15), p<0.001], older age [OR(95% CI): 0.98(0.96–0.99), p=0.003], greater INR level [OR(95% CI): 0.48(0.28–0.81), p=0.007] in patients without ACLF. Multivariate Cox proportional hazard model analysis indicated that UGH did not increase mortality at different times in cirrhotic patients with acute decompensation. Conclusions: UGH is a frequent complication in cirrhotic patients with AD, even those with ACLF. Positive fecal occult blood tests and previous GI bleeding were shown to be associated with the risk of UGH. UGH did not significantly increase the risk of mortality in cirrhotic patients with AD or ACLF.


  • Multidrug-resistant bacterial infections in cirrhotic patients: an epidemiological study

    by Ruihong Zhao, Jianke Ma, Pengcheng Li, Hong Fang, Shanshan Sun, Wei Wu, Jingdan Chen, Hong Zhao, Linfeng Jin, Yu Shi, et al.

    The purpose of this study is to describe the epidemiological features of bacterial infections caused by multidrug-resistant (MDR) bacteria in cirrhotic patients and their impact on mortality. A retrospective study of cirrhotic patients with culture-confirmed bacterial infections was performed between 2011 and 2017. A total of 635 episodes in 563 patients with cirrhosis were included. Bacterial infections caused by MDR isolates accounted for 44.1% (280/635) of the episodes, nearly half of which were hospital acquired (48.4%). The most common MDR isolation site was the respiratory tract (36.4%, 102 episodes), followed by the abdominal cavity (35.4%, 99 episodes). Of the MDR isolates, carbapenem-resistant Enterobacteriaceae (CRE) (91 episodes) were the most common. Patients infected with MDR bacteria had significantly higher mortality than those not infected (25.1% vs 17.4%, p = 0.025). However, this increased mortality could be largely attributed to methicillin-resistant Staphylococcus aureus (MRSA). After adjustment for age, sex, and the model for end-stage liver disease (MELD) score, only MRSA infection was an independent risk factor for 28-day mortality in the multivariable Cox proportional hazard regression model analysis (HR, 2.964, 95% CI (1.175-7.478), p = 0.021). MDR bacterial infections, especially CRE, have become frequent in patients with cirrhosis in recent years, with MRSA infections significantly increasing short-term mortality.